Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shaanxi Yida Hemophilia Institute is a specialized medical research and clinical organization based in Xi'an, China, dedicated to the treatment and management of hemophilia and related bleeding disorders. Founded by Sun Yida, the institute is notable for its integrated therapeutic approach that combines traditional Chinese medicine (TCM) with modern hematological practices, such as clotting factor replacement therapy. The organization provides proprietary formulations known as the Yida series, which are designed to reduce bleeding frequency and assist in the long-term rehabilitation of patients. In addition to clinical services, the institute focuses on patient education, advocacy, and the development of specialized nursing protocols for hemophiliacs. It operates as a significant regional center for blood disorder research, aiming to improve the accessibility of specialized care in the Shaanxi province.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shaanxi Yida Hemophilia Institute.